menu toggle

Biosimilars: Strategies for Utilization in the Health System Setting

By IHOC

As biosimilars re-shape the treatment landscape, they’re creating new opportunities for health system pharmacy leaders to lead the evaluation and education process for product selection.

Listen to this webinar to learn:

  • How a better understanding of biosimilars will facilitate your partnership with the P&T Committees and enhance discussions of biosimilar similarities with physician stakeholders
  • How to guide your health system on evaluating biosimilars for formulary inclusion
  • How to use an actionable tool comparing biosimilars to reference products that will ultimately aid your health system pharmacy

Related Content

Data Helping Define Value-Based Care

Inverted color AmerisourceBergen icon
IHOC
June 2019

Patient-Centered Care: The Case for Site Expansion to Include Health System Specialty Pharmacy

KChambersHeadshot
Kristin Chambers
IHOC
November 2018

Health system specialty pharmacies are uniquely positioned to provide coordinated care to patients with complex and chronic conditions. With shared access to the patient's health record, multidisciplinary teams deliver integrated care that increases speed to therapy, enhances the patient experience and improves outcomes.

Health Systems

Biosimilars: Key Considerations

Inverted color AmerisourceBergen icon
IHOC
June 2018

As biosimilars launch, they are shaping the treatment landscape. These new options are also creating new opportunities for health system pharmacy leaders to expand their influence on patient outcomes.